A closer look at Pfizer v Orifarm, SPCs and the specific mechanism
The CJEU set several precedents for the specific mechanism’s scope over supplementary protection certificates, in a decision IP attorneys say cements the connection between SPCs and basic patents
IP lawyers say the connection between SPCs and basic patents has been strengthened by the CJEU last week confirming the scope of the specific mechanism regarding parallel importation of supplementary protection certificate-protected products.
In the case of Pfizer v Orifarm...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.